Analysis of the costs of a large prevention trial.

[1]  A. Detsky.  Are clinical trials a cost-effective investment? , 1989, JAMA.

[2]  N. Urban,et al.  The Women's Health Trial as an Investment , 1989, Medical decision making : an international journal of the Society for Medical Decision Making.

[3]  W Insull,et al.  Statistical design of the Women's Health Trial. , 1988, Controlled clinical trials.

[4]  S. Piantadosi,et al.  A method for predicting accrual, cost, and paper flow in clinical trials. , 1987, Controlled clinical trials.

[5]  R. L. Prentice,et al.  A case-cohort design for epidemiologic cohort studies and disease prevention trials , 1986 .

[6]  C. Meinert.  Clinical Trials: Design, Conduct, and Analysis , 1986 .

[7]  C. Baines.  Impediments to recruitment in the Canadian National Breast Screening Study: response and resolution. , 1984, Controlled clinical trials.

[8]  M A Moussa,et al.  Planning a clinical trial with allowance for cost and patient recruitment rate. , 1984, Computer programs in biomedicine.

[9]  M C Weinstein,et al.  Cost-effective priorities for cancer prevention. , 1983, Science.

[10]  H. Guess,et al.  Use of cost-effectiveness analysis in planning cancer chemoprophylaxis trials. , 1983, Controlled clinical trials.

[11]  E. Sondik,et al.  Initiating large-scale clinical trials. , 1982, Controlled clinical trials.

[12]  M H Gail,et al.  Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation. , 1981, Journal of chronic diseases.

[13]  E. Sondik,et al.  High risk subjects and the cost of large field trials. , 1974, Journal of chronic diseases.

[14]  S. George,et al.  Planning the size and duration of a clinical trial studying the time to some critical event. , 1974, Journal of chronic diseases.